Skip to main content
Premium Trial:

Request an Annual Quote

German Scientists Pinpoint New Ovarian Cancer Biomarker

NEW YORK, Sept. 12 (GenomeWeb News) - Scientists at the German Cancer Research Center in Heidelberg, Germany published findings in this week's Lancet that described a protein biomarker for uterine and ovarian cancers with poor prognosis.


Peter Altevogt and others found the marker, L1 glycoprotein, using immunological and genotyping profiles of women with ovarian and uterine cancers. Presence of the marker indicates a poor prognosis.


Ovarian cancer has been the focus of several protein biomarker profiling studies over the past two years. See coverage in ProteoMonitor.


The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.